Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease - An epidemiological perspective

被引:124
作者
Luchsinger, Jose Alejandro [1 ,2 ,3 ,4 ]
机构
[1] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA
[2] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA
[3] Columbia Univ Coll Phys & Surg, Dept Med, Div Gen Med, New York, NY 10032 USA
[4] Columbia Univ, Joseph P Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
基金
美国国家卫生研究院;
关键词
adiposity; overweight; obesity; hyperinsulinemia; insulin; glucose; diabetes; Alzheimer's disease; cognitive impairment;
D O I
10.1016/j.ejphar.2008.02.048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this manuscript is to provide a comprehensive review of the epidemiologic evidence linking the continuum of adiposity, hyperinsulinemia, and diabetes with Alzheimer's disease. The mechanisms for these associations remain to be elucidated, but may include direct actions from insulin, advanced products of glycosilation, cerebrovascular disease, and products of adipose tissue metabolism. Elevated adiposity in middle age is related to a higher risk of Alzheimer's disease. The evidence relating adiposity in old age to Alzheimer's disease is conflicting. Several studies have shown that hyperinsulinemia, a consequence of higher adiposity and insulin resistance, is also related to a higher risk of Alzheimer's disease. Hyperinsulinemia is a risk factor for diabetes, and numerous studies have shown a relation of diabetes with higher Alzheimer's disease risk. Most studies fail the take into account the continuum linking these risk factors which may result in underestimation of their importance in Alzheimer's disease. The implication of these associations is that a large proportion of the world population may be at increased risk of Alzheimer's disease given the trends for increasing prevalence of overweight, obesity, hyperinsulinemia, and diabetes. However, if proven causal, these associations also present a unique opportunity for prevention and treatment of Alzheimer's disease. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:119 / 129
页数:11
相关论文
共 109 条
[1]   Lilly Lecture, 2003 - The struggle for mastery in insulin action: From triumvirate to republic [J].
Accili, D .
DIABETES, 2004, 53 (07) :1633-1642
[2]  
Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275
[3]  
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[4]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[5]   HUMAN-BODY COMPOSITION AND THE EPIDEMIOLOGY OF CHRONIC DISEASE [J].
BAUMGARTNER, RN ;
HEYMSFIELD, SB ;
ROCHE, AF .
OBESITY RESEARCH, 1995, 3 (01) :73-95
[6]   Diabetes mellitus in midlife and the risk of dementia three decades later [J].
Beeri, MS ;
Goldbourt, U ;
Silverman, JM ;
Noy, S ;
Schmeidler, J ;
Ravona-Springer, R ;
Sverdlick, A ;
Davidson, M .
NEUROLOGY, 2004, 63 (10) :1902-1907
[7]   Vascular risks and incident dementia: Results from a cohort study of the very old [J].
Brayne, C ;
Gill, C ;
Huppert, FA ;
Barkley, C ;
Gehlhaar, E ;
Girling, DM ;
O'Connor, DW ;
Paykel, ES .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1998, 9 (03) :175-180
[8]   Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset [J].
Brookmeyer, R ;
Gray, S ;
Kawas, C .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) :1337-1342
[9]   Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria - Results of the Leipzig Longitudinal Study of the Aged (LEILA75+) [J].
Busse, A ;
Bischkopf, J ;
Riedel-Heller, SG ;
Angermeyer, MC .
BRITISH JOURNAL OF PSYCHIATRY, 2003, 182 :449-454
[10]   RISK-FACTORS FOR NIDDM IN WHITE-POPULATION - PARIS PROSPECTIVE-STUDY [J].
CHARLES, MA ;
FONTBONNE, A ;
THIBULT, N ;
WARNET, JM ;
ROSSELIN, GE ;
ESCHWEGE, E .
DIABETES, 1991, 40 (07) :796-799